Dr. Abularrage specializes in vascular and endovascular surgery, with a specific interest in minimally invasive techniques for lower extremity peripheral arterial disease and aneurysm repair. His clinical interests include limb preservation, Diabetic peripheral arterial disease and limb salvage, aortic aneurysms, endovascular aneurysm repair, visceral stents and bypass, and carotid stents and carotid endarterectomy. Dr. Abularrage is an active researcher within the department and has published widely on outcomes research using large, national databases. Recently, Dr. Abularrage and his team have published their outcomes of patients treated in the Multidisciplinary Diabetic Foot & Wound Clinic, showing significantly lower amputation rates compared to national benchmarks. Dr. Abularrage is a distinguished fellow to the Society of the American Board of Surgery, and recipient of the Zehner Award and the R. Clement Darling, Jr. Award. He is nationally renowned for his work in Diabetic peripheral arterial disease and limb preservation. Dr. Abularrage is rated as a Distinguished provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Peripheral Artery Disease, Carotid Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Stent Placement.

Dr. Moon’s area of clinical expertise is infectious diseases. She earned her M.D. at the Ross University School of Medicine. Dr. Moon completed her residency at Allegheny General Hospital and performed a fellowship in infectious diseases at Penn State Milton S. Hershey Medical Center. Dr. Moon is rated as a Distinguished provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Hepatitis C, Hepatitis, Osteomyelitis, and HIV/AIDS.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.

Dr. Hicks specializes in congenital aortic pathologies including aberrant subclavian arteries and aortic coarctation, thoracic and abdominal aortic aneurysms, complex lower extremity revascularization including lower extremity bypasses and stenting, and carotid endarterectomy. She is skilled in both open and endovascular surgery for the treatment of aortic and peripheral disease. She is also accomplished in clinical research with over 130 peer-reviewed publications and numerous textbook chapters; her research interests include clinical outcomes in aneurysm repair and lower extremity revascularization, as well as high-value care in vascular surgery. A distinguished fellow of the American Board of Surgery, Dr. Hicks is the recipient of the Department of Surgery Rothman Early Career Development Award for Surgical Research and was selected as a Visiting Scholar to the American Board of Medical Specialties for 2018-2019. She is also an appointed member of a CMS Clinical Expert Subcommittee tasked with refining peripheral vascular disease cost measures for implementation in the Quality Payment Program. LinkedIn https://www.linkedin.com/in/caitlin-hicks-b211b617/. Dr. Hicks is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Carotid Artery Disease, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Aneurysm Repair.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Erica Johnson, M.D., earned an undergraduate degree at the University of Virginia, followed by a medical degree at the University of Maryland. She completed a residency in internal medicine at Walter Reed Army Medical Center in Washington, DC, and a fellowship in infectious diseases at Brooke Army Medical Center (BAMC) in San Antonio, Texas. Dr. Johnson serves as a fellow of the American College of Physicians, and recently completed 11 years as a medical corps officer in the United States Army, where she served as associate program director for the San Antonio Uniformed Services Health Education Consortium (SAUSHEC) Internal Medicine Residency and Infectious Disease Fellowship Programs at BAMC. She also held an appointment as assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Johnson has research interests in infections associated with combat trauma and deployment infection control, as well as HIV outcomes, gender-based health issues, and disparities in care. Lab Website Erica Johnson Lab - Lab Website Research in the Erica Johnson Lab investigates infection control in military deployment environments as well as infections that are associated with combat trauma. We explore topics such as HIV outcomes, gender-based health issues and disparities in care. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Lum is a clinically busy vascular surgeon specializing in the open and endovascular treatment of peripheral arterial disease, cartoid artery disease, dialysis access, mesenteric occlusive disease, arterial aneurysms and venous disease. In addition, he has a strong clinical & research interest in thoracic outlet syndrome. Dr Lum also has a Masters in Public Health from the Johns Hopkins School of Public Health. Dr. Lum is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Thoracic Outlet Syndrome, Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Osteotomy.

Dr. Stephen Berry is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV medicine and general infectious diseases. He serves as the Vice Chair for Quality, Safety and Service in the Department of Medicine. Dr. Berry graduated summa cum laude from Emory University and joined the Peace Corps to work as a science teacher in Malawi. He then completed medical school, an internal medicine residency and a chief resident year at the University of Pennsylvania School of Medicine. He performed a fellowship in infectious diseases at Johns Hopkins as well as a Ph.D. from the graduate training program in clinical investigation. Dr. Berry joined the Johns Hopkins faculty in 2010. Dr. Berry’s research focuses on health services utilization and quality and secondary HIV prevention among persons living with HIV. He also focuses on the role of quality metrics in the US healthcare system's transition to value based care. Dr. Berry is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Myelitis, HIV/AIDS, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Plastic and reconstructive surgeon Barkat Ali cares for patients requiring complex reconstructive surgery after trauma and cancer, or those seeking cosmetic plastic surgery such as body contouring. Dr. Ali has a wealth of surgical experience treating patients and a strong commitment to patient-centered care. Dr. Ali earned his medical degree from Agha Khan University Medical College in Pakistan, and completed residency programs in general surgery and plastic surgery at the University of New Mexico School of Medicine. He also completed fellowships in hand surgery at the Christine M. Kleinert Institute for Hand and Micro Surgery at the University of Louisville School of Medicine, and a fellowship in reconstructive microsurgery at Memorial Sloan Kettering Cancer Center. Dr. Ali is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Apert Syndrome, Acrocephalopolydactyly, Saethre-Chotzen Syndrome, Glossectomy, and Mastectomy.

Charles Bornmann is an Infectious Disease provider in Baltimore, Maryland. Dr. Bornmann is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Infective Endocarditis, Sepsis, Osteomyelitis, and Myelitis.

James Doub is an Infectious Disease provider in Baltimore, Maryland. Dr. Doub is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Infectious Arthritis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Osteomyelitis, and Cellulitis. Dr. Doub is currently accepting new patients.

Joel Chua is an Infectious Disease provider in Baltimore, Maryland. Dr. Chua is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Hepatitis, and Osteomyelitis.

Kathryn Schlaffer is an Infectious Disease provider in Baltimore, Maryland. Dr. Schlaffer is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Myelitis, and HIV/AIDS. Dr. Schlaffer is currently accepting new patients.

Uzoamaka Eke is an Infectious Disease provider in Baltimore, Maryland. Dr. Eke is rated as an Advanced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Osteomyelitis, Sepsis, Strep Throat, and Osteomyelitis in Children. Dr. Eke is currently accepting new patients.

Tara Hebert, M.D., practices internal medicine at Johns Hopkins Community Physicians East Baltimore Medical Center. She received her medical degree from Johns Hopkins University School of Medicine, and also completed her residency in internal medicine at Johns Hopkins Medicine School of Medicine. Dr. Hebert is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Maturity Onset Diabetes of the Young, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Matthew Robinson, MD, is Assistant Professor in the Division of Infectious Diseases at Johns Hopkins University School of Medicine. He is interested in leveraging diagnostic innovation and precision medicine to reduce diagnostic and prognostic uncertainty for infectious diseases. His current projects include applications in global health, antimicrobial resistance, antibiotic stewardship, infection control, COVID-19, acute febrile illness, and tuberculosis. After undergraduate and medical school at Northwestern University, he completed internal medicine residency at New York University and Infectious Diseases fellowship at Johns Hopkins School of Medicine. During medical school, he worked at the Chinese Center for Disease Control and Prevention in Beijing, China under a Doris Duke International Clinical Research Fellowship. He also served as a clinician educator in internal medicine in Gulu, Uganda at the Gulu University Faculty of Medicine as a Global Health Service Partnership volunteer. As a fellow, he pursued a Fogarty Global Health Fellowship in Pune, India and an Antibacterial Resistance Leadership Group Fellowship. Since joining the faculty in 2019, Dr. Robinson has been supported by the Centers for Disease Control and Prevention, National Institutes of Health, and Food and Drug Administration. The focus of his work in antimicrobial resistance, antibiotic stewardship, infection control has been to characterize drug-resistant Gram-negative infections in India. His work with the Johns Hopkins Precision Medicine Center of Excellence for COVID-19 has included applying machine learning and causal inference techniques to predict COVID-19 outcomes. He has contributed to SARS-CoV-2 diagnostic development through the NIH Rapid Acceleration of Diagnostics (RADx) initiative and through collaborative development of other novel diagnostics. Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Togaviridae Disease, and Dengue Fever.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as an Experienced provider by MediFind in the treatment of Osteomyelitis. His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.